Correlation Between Black Diamond and Icosavax
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Icosavax, you can compare the effects of market volatilities on Black Diamond and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Icosavax.
Diversification Opportunities for Black Diamond and Icosavax
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Black and Icosavax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Black Diamond i.e., Black Diamond and Icosavax go up and down completely randomly.
Pair Corralation between Black Diamond and Icosavax
If you would invest (100.00) in Icosavax on November 28, 2024 and sell it today you would earn a total of 100.00 from holding Icosavax or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Black Diamond Therapeutics vs. Icosavax
Performance |
Timeline |
Black Diamond Therap |
Icosavax |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Black Diamond and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Black Diamond and Icosavax
The main advantage of trading using opposite Black Diamond and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data |